XML 29 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Shareholders' Equity
12 Months Ended
Dec. 31, 2017
Shareholders' Equity [Abstract]  
SHAREHOLDERS' EQUITY

NOTE 7 - SHAREHOLDERS’ EQUITY

 

 a.Share capital:

 

The Company’s ordinary shares are traded in the United States on the NASDAQ National Market, under the symbol MNDO.

 

 b.Treasury shares:

 

During the period between September 2008 and December 2009, the Company has purchased an aggregate amount of 3,165,092 ordinary shares for a total consideration of approximately $2.8 million. Currently, the Company does not have an active buyback plan. As of December 31, 2017 the remaining treasury shares are 2,352,592 which amounted to $1.6 million after exercise of options issued to employees from treasury shares in the amount of $53 thousand, $85 thousand and $171 thousand in the years ended December 31, 2017, 2016 and 2015 respectively.

 

 c.Dividend:

 

Dividends paid per share in the years ended December 31, 2017, 2016 and 2015 were $0.32, $0.27 and $0.30, respectively.

 

The Company paid dividends to its shareholders in the amounts of $6.2 million, $5.2 million and $5.8 million during the years ended December 31, 2017, 2016 and 2015, respectively.

 

 d.Stock option plans:

 

In 2011, the Board of Directors and the 2011 Annual General Meeting of the Company’s shareholders approved a share incentive plan (the “2011 Share Incentive Plan”). Under the 2011 Share Incentive Plan, options for up to 1,800,000 ordinary shares of NIS 0.01 par value are to be granted to employees of the Company and its subsidiaries, directors, consultants or contractors of the Company.

 

Each option can be exercised to purchase one ordinary share. Immediately upon issuance, the ordinary shares issuable upon the exercise of the options will confer on holders the same rights as the other ordinary shares.

 

The Board of Directors determines the exercise price and the vesting period of the options granted. The outstanding options granted under the above mentioned plan vest over 2-4 years. Options not exercised will expire 5 years after the day of grant.

 

The compensation costs charged against income for all of the Company’s equity incentive plans during the years ended December 31, 2017, 2016 and 2015 were approximately $182 thousand, $137 thousand and $138 thousand, respectively without any reduction in income taxes.

 

As a result of a change made to Section 102 of the Israeli Income Tax Ordinance as part of the Israeli tax reform of 2003, and pursuant to an election made by the Company thereunder, Israeli employees (except for employees who are deemed “Controlling Members” under the Israeli Income Tax Ordinance) will be subject to a lower tax rate on capital gains accruing to them in respect of Section 102 awards made after December 31, 2002. However, the Company will not be allowed to claim as an expense for tax purposes the amounts credited to such employees as a benefit when the related capital gains tax is payable by them, as it had previously been entitled to do under Section 102.

 

The following is a summary of the status of the 2011 Share Incentive Plan as of December 31, 2017, 2016 and 2015, and changes during the years ended on those dates:

 

1)

 

   Years ended December 31, 
   2 0 1 7  2 0 1 6  2 0 1 5 
   Number  Weighted average exercise price  Number  Weighted average exercise price  Number  Weighted average exercise price 
                    
 Options outstanding at beginning of year  875,500  $1.60   710,300  $2.51   851,600  $2.63 
 Changes during year:                        
 Granted (a)  90,000  $0.65   344,000  $0.003   116,800  $1.66 
 Exercised  (46,000) $1.15   (59,000) $1.45   (92,100) $1.85 
 Forfeited  (78,400) $1.41   (117,800) $2.49   (166,000) $2.88 
 Expired  (28,000) $2.95   (2,000) $2.16   -   - 
 Options outstanding at end of year  813,100  $1.49   875,500  $1.60   710,300  $2.51 
                          
 Options exercisable at end of year  303,000  $2.90   246,500  $2.87   51,000  $1.98 
 Vested and expected to vest at end of year  731,517  $1.72                 
                          
 Weighted average grant date fair value of options granted during the year (b)     $1.30      $1.46      $0.94 

 

(a)In the year ended December 31, 2017 the options were granted with an exercise price equal to the average closing price per share of the Company’s ordinary shares on the stock market during the 30 trading day period immediately preceding the date of grant of such option or with an exercise price equal to par value of NIS 0.01.

 

In the year ended December 31, 2016 the options were granted with an exercise price equal to par value of NIS 0.01.

 

In the year ended December 31, 2015 the options were granted with an exercise price equal to the average closing price per share of the Company’s ordinary shares on the stock market during the 30 trading day period immediately preceding the date of grant of such option or with an exercise price equal to par value of NIS 0.01.

 

(b)The fair value of each stock option granted is computed on the date of grant according to the Black-Scholes option-pricing model with the following assumptions:

 

   Years ended December 31, 
   2 0 1 7  2 0 1 6  2 0 1 5 
           
 Dividend yield  11%  11%  10%
              
 Expected volatility*  35%  35%  48%
              
 Average risk-free interest rate  1.9%  2.0%  1.5%
              
 Expected average term - in years  3.88   3.88   3.88 

 

*Volatility is based on historical volatility of the Company’s share price for periods matching the expected term of the option until exercise.

 

As of December 31, 2017 there were approximately $447 thousand of total unrecognized compensation costs, net of expected forfeitures, related to nonvested share-based compensation awards granted under the stock option plan. The costs are expected to be recognized over a weighted average period of 1.41 years.

 

2)The following table summarizes information about options outstanding and exercisable as of December 31, 2017:

 

   Options Outstanding  Options Exercisable 
  
 
Range of exercise prices
 Number
outstanding
at
December 31,
2 0 1 7
  Weighted
average
remaining
contractual
life
   
Weighted
average
exercise
price
  Number
exercisable
at
December 31,
2 0 1 7
  Weighted
average
remaining
contractual
life
   
 Weighted
average
exercise
price
 
      Years        Years    
 $ 0.003 – 2.160  409,600   3.73  $0.10   18,000   0.18  $2.16 
 $ 2.425 – 2.947  403,500   2.01  $2.91   285,000   1.85  $2.94 
    813,100   2.88  $1.49   303,000   1.75  $2.90 

 

The total intrinsic value of options exercised during the years ended December 31, 2017, 2016 and 2015 were approximately $70 thousand, $51 thousand and $176 thousand, respectively. As of December 31, 2017, the aggregate intrinsic value of the outstanding options is $1.1 million, and the aggregate intrinsic value of the exercisable options is $11 thousand.